FDA and EMA Simultaneously warns of chloroquine

Shell Offshore Inc said that its affiliate, Shell E and P Offshore Services BV, will exercise a contractual right to purchase the Turritella floating, production, storage and offloading (FPSO) vessel from SBM Offshore.
The vessel is contracted for the Stones deep-water development in the Gulf of Mexico, which began production last year. Shell and SBM will work over the next several months to achieve a safe, smooth transition of the vessel operations.
Transitioning the ownership and operations of the vessel to Shell affiliates allows the company to pursue additional efficiencies and achieve cost improvements to deliver shareholder value at Stones with a continued commitment to operational excellence and safety. The Stones development is the world’s deepest offshore oil and gas project and is scheduled to deliver approximately 50,000-barrels of oil equivalent per day (boe/d) by the end of this year.
The Turritella FPSO has a daily production capacity of approximately 60,000 barrels of oil and 15 million cubic feet of natural gas and fits well within Shell’s global, deep-water portfolio, which includes operations in the Gulf of Mexico, Brazil, Nigeria, and Malaysia. Competitive, deep-water oil resources are a growth priority for Shell with global production expected to reach more than 900-thousand boe/d by the early 2020s.
Currently, Shell has three additional Gulf of Mexico deepwater projects under construction – Appomattox, Kaikias, and Coulomb Phase 2 – as well as options for additional subsea tiebacks and Vito, a potential, new hub in the region.
Looking for chemical products? Let suppliers reach out to you!
2026-06-10
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Did Hydroxychloroquine Cause Thousands of Deaths During the COVID-19 Pandemic?
-
EMA:The efficacy of chloroquine against the COVID-19 has not been confirmed
-
Quality or quantity? The quality of hydroxychloroquine donated by Bayer
-
Sanofi to donate 100 million doses of hydroxychloroquine across 50 countries
-
To increase supply, FDA issued special guidelines for chloroquine drugs
-
After 'initial shock,' generics supply chain likely to weather COVID-19 blows
-
Chinese APIs flowing but India ban hinders U.S. approval of hydroxychloroquine
-
关于进一步规范化学品信息发布、加强全球管制目录宣导的公告 Announcement on Further Standardizing the Release of Chemical Information and Strengthening Public Awareness of Global Control Lists
-
关于将4-amino-1-boc-piperidine、tert-buty 4-aminopiperidine-1-carboxylate产品列入《ECHEMI平台禁限售商品目录》的公告 Announcement on Including 4-amino-1-boc-piperidine and tert-buty 4-aminopiperidine-1-carboxylate in the Announcement on the List of Prohibited Sales of Prohibited and Controlled Items on ECHEMI
-
“全球展会数据”功能上线公告 Announcement on the Launch of the “Global Exhibition Data” Function
Recommend Reading
-
关于全面排查下架易制毒及易制爆产品信息的公告 Announcement on the Comprehensive Review and Removal of Product Information Related to Precursor and Explosive Precursor Chemicals
-
关于加强防范钓鱼邮件的通知 Notification on Strengthening Anti-Phishing Measures
-
Company Name Change Announcement
-
Supporting Each Other | ECHEMI Employees Voluntarily Raise Funds for Flood Relief in Southern Thailand
-
Chemical Reactions and Uses of Stilbene
-
Uses of Dithiothreitol in Laboratories
-
Insufficient Cost Support, Coking Coal Market Prices Remain Stable for Now
-
Symrise Launches “Care & Wellness” Division to Strengthen Beauty–Health Integration